Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$247.61 USD
+4.29 (1.76%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $247.94 +0.33 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.75 | 9.46% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 78.67%. Look out for ALNY's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.75 per share, reflecting a year-over-year increase of 66.06%.
Earnings History
Price & Consensus
Zacks News for ALNY
Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services